Optimi Health Corp. Common Shares (OPTH)

About OPTH

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

optimihealth.ca/

Fundamentals

1-day range

$4.81$4.93

Market cap

$16.61M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-15.59

Dividend yield

—

Beta

0.94

Avg. volume

92.8K

Optimi Health Corp. Common Shares Competitors

Chosen by industry and closest market cap.

• OPTH

  Optimi Health Corp. Common Shares

  $4.93

  ▼ 0.80%
  Market cap $16.61MP/E —
  $0.195$11.4
• SKYE

  Skye Bioscience Inc. Common Stock

  $1.81

  ▼ 7.18%
  Market cap $16.58MP/E —
  $1.84$39.92
• CYCN

  Cyclerion Therapeutics Inc. Common Stock

  $3.81

  ▼ 4.51%
  Market cap $16.67MP/E —
  $1.03$8.48
• LPCN

  Lipocine Inc. Common Stock

  $2.2

  ▼ 1.35%
  Market cap $17.56MP/E —
  $1.81$12.37
• NCEL

  NewcelX Ltd. Ordinary Shares

  $3.19

  ▼ 6.73%
  Market cap $17.98MP/E —
  $1.83$24.6
• SCNX

  Scienture Holdings Inc. Common Stock

  $0.3938

  ▲ 3.63%
  Market cap $15.14MP/E —
  $0.2382$2.6
• HIND

  Vyome Holdings Inc. Common Stock

  $2.2

  ▼ 0.23%
  Market cap $15.02MP/E —
  $1.75$12.87

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances
  Yahoo · 8/19/2026
• Optimi Health Establishes Discretionary Equity Facility
  Yahoo · 8/14/2026